Véronique Regnault Selected Research

Low Cardiac Output

9/2013

Is thrombosis a contributor to heart failure pathophysiology? Possible mechanisms, therapeutic opportunities, and clinical investigation challenges.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Véronique Regnault Research Topics

Disease

15	Thrombosis (Thrombus) 02/2024 - 01/2003
7	Inflammation (Inflammations) 01/2022 - 03/2008
7	Thrombophilia 01/2021 - 01/2003
6	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 02/2024 - 12/2007
5	Hypertension (High Blood Pressure) 01/2017 - 01/2012
4	Activated Protein C Resistance (APC Resistance) 11/2020 - 01/2003
3	Atherosclerosis 01/2022 - 03/2008
3	Heart Failure 01/2019 - 09/2013
2	COVID-19 01/2021 - 01/2021
2	Hemorrhage 01/2021 - 06/2003
2	Renal Insufficiency (Renal Failure) 01/2021 - 01/2021
2	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2017 - 09/2013
2	Obesity 01/2017 - 09/2012
2	Thrombocytopenia (Thrombopenia) 12/2007 - 06/2003
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 11/2023
1	Colitis 11/2023
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2022
1	Neoplasms (Cancer) 01/2022
1	Hyperplasia 01/2022
1	Vascular Calcification 01/2020
1	Type 2 Diabetes Mellitus (MODY) 11/2017
1	Pulmonary Hypertension 06/2017
1	Pulmonary Arterial Hypertension 06/2017
1	Hypoprothrombinemias (Prothrombin Deficiency) 07/2016
1	Hypotension (Low Blood Pressure) 09/2013
1	Body Weight (Weight, Body) 09/2013
1	Bradycardia 09/2013
1	Low Cardiac Output 09/2013
1	Insulin Resistance 09/2013
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2013
1	Atherosclerotic Plaque (Atheroma) 07/2012

Drug/Important Bio-Agent (IBA)

10	Thrombin FDA Link 02/2024 - 01/2003
7	Protein CIBA 11/2020 - 01/2003
6	AntibodiesIBA 01/2021 - 12/2007
5	Antiphospholipid AntibodiesIBA 11/2020 - 01/2004
4	von Willebrand FactorIBA 11/2023 - 04/2015
3	AnticoagulantsIBA 02/2024 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2003
3	LipidsIBA 01/2022 - 07/2012
2	CytokinesIBA 01/2022 - 10/2019
2	Glycoproteins (Glycoprotein)IBA 01/2022 - 04/2015
2	Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA 01/2021 - 07/2016
2	Thromboplastin (Tissue Factor)IBA 01/2021 - 10/2019
2	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 01/2021
2	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2021
2	Immunoglobulin G (IgG)IBA 11/2020 - 11/2015
2	Prothrombin (Factor II)IBA 12/2018 - 02/2009
2	AntithrombinsIBA 01/2017 - 01/2004
2	InterleukinsIBA 01/2017 - 12/2007
2	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 05/2014 - 01/2012
2	AldosteroneIBA 05/2014 - 01/2012
2	Heparin (Liquaemin)FDA LinkGeneric 12/2007 - 06/2003
2	EnzymesIBA 12/2007 - 04/2003
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2022
1	G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA 01/2022
1	resolvin D2IBA 01/2022
1	ApolipoproteinsIBA 01/2022
1	Histones (Histone)IBA 01/2021
1	Deoxyribonucleases (DNase)FDA Link 01/2021
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Cardiolipins (Cardiolipin)IBA 01/2021
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2021
1	Peroxidase (Myeloperoxidase)IBA 01/2021
1	Interleukin-6 (Interleukin 6)IBA 01/2021
1	Interleukin-8 (Interleukin 8)IBA 01/2021
1	lipoprotein-associated coagulation inhibitor (TFPI)IBA 01/2021
1	CollagenIBA 01/2020
1	ElastinIBA 01/2020
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020
1	Polyurethanes (Polyurethane)IBA 10/2019
1	CobaltIBA 10/2019
1	Phospholipids (Phosphatides)FDA LinkGeneric 12/2018
1	ThrombomodulinIBA 12/2018
1	Carrier Proteins (Binding Protein)IBA 12/2018
1	Liraglutide FDA Link 11/2017
1	Cytoskeletal ProteinsIBA 10/2017
1	7-(N-(3-aminopropyl)amino)heptan-2-oneIBA 06/2017
1	Blood Coagulation Factors (Coagulation Factor)IBA 01/2017
1	myocardinIBA 01/2017
1	Interleukin-13IBA 01/2017
1	Nonesterified Fatty Acids (NEFA)IBA 01/2017
1	Enzyme Inhibitors (Inhibitors, Enzyme)IBA 04/2015
1	Angiotensin IIIBA 04/2015
1	Valsartan (Vals)FDA Link 01/2015
1	ferric chlorideIBA 05/2014
1	Endothelial Protein C ReceptorIBA 05/2014
1	pyrrolineIBA 09/2013
1	(3- chloro- 2- methylphenyl)- (4- methyl- 4,5- dihydro- 3H- pyrrol- 2- yl)amineIBA 09/2013
1	Adenosine (Adenocard)FDA LinkGeneric 09/2013
1	Fibrinolytic Agents (Antithrombotic Agents)IBA 09/2013
1	Glucose (Dextrose)FDA LinkGeneric 09/2013
1	Warfarin (Coumadin)FDA LinkGeneric 09/2013
1	Proteinase-Activated ReceptorsIBA 09/2013
1	AdiponectinIBA 09/2013
1	Fatty Acids (Saturated Fatty Acids)IBA 09/2012
1	CholesterolIBA 07/2012
1	LDL Lipoproteins (beta Lipoproteins)IBA 07/2012

Therapy/Procedure

2	Therapeutics 02/2024 - 06/2003
2	Ligation 01/2022 - 11/2011
1	Critical Care (Surgical Intensive Care) 01/2021